You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,129,343


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,129,343
Title:Acylated GLP-1 compounds
Abstract: Protracted GLP-1 compounds and therapeutic uses thereof.
Inventor(s): Lau; Jesper (Farum, DK), Bloch; Paw (Taastrup, DK), Hansen; Thomas Kruse (Herlev, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:11/908,834
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,129,343
Patent Claims: 1. A compound of the structure ##STR00059## where the amino acid sequence is that of SEQ ID NO: 7.

2. A pharmaceutical composition comprising a compound of the structure ##STR00060## where the amino acid sequence is that of SEQ ID NO: 7, and a pharmaceutically acceptable excipient.

3. A method for treating type 2 diabetes in a subject, said method comprising administering to a subject in need of such treatment an effective amount of a pharmaceutical composition comprising a compound of the structure ##STR00061## where the amino acid sequence is that of SEQ ID NO: 7, and a pharmaceutically acceptable excipient.

4. A compound having the following name N-.epsilon..sup.26-[2-(2-[2-(2-[2-(2-[4-(17-Carboxyheptadecanoylamino)-4(- S)-carboxybutyrylamino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl][Aib- 8,Arg34]GLP-1-(7-37)peptide.

5. A pharmaceutical composition comprising a compound having the following name N-.epsilon..sup.26-[2-(2-[2-(2-[2-(2-[4-(17-Carboxyheptadecanoylamino)-4(- S)-carboxybutyrylamino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl][Aib- 8,Arg34]GLP-1-(7-37)peptide and a pharmaceutically acceptable excipient.

6. A method for treating type 2 diabetes in a subject, said method comprising administering to a subject in need of such treatment an effective amount of a pharmaceutical composition comprising a compound having the following name N-.epsilon..sup.26-[2-(2-[2-(2-[2-(2-[4-(17-Carboxyheptadecanoylamino)-4(- S)-carboxybutyrylamino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl][Aib- 8,Arg34]GLP-1-(7-37)peptide and a pharmaceutically acceptable excipient.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.